GLUT1, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-GLUT1, Human antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | GLUT1, Human |
| Clone | REAL763 |
| Host Species | Recombinant Human |
| Reactive Species | human, mouse |
| Isotype | n/a |
| Format | allophycocyanin (APC) conjugate |
| Size | 200 µL |
| Concentration | n/a |
| Applications | MICS (MACSima Imaging Cyclic Staining), Immunohistochemistry, Immunofluorescence |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | GLUT1 Antibody, anti-human, APC, REAdye_lease™. Clone REAL763 is an antibody fragment derived from the full GLUT1 antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAdye_lease Complex to bind markers with high avidity. | Clone REAL763 recognizes the human GLUT1 antigen, an insulin-dependent integral membrane protein that is also known as glucose transporter type 1, HepG2 glucose transporter or SLC2A1. GLUT1 is mainly found in erythrocytes and in the central nervous system and has a broad substrate specificity. Mutations in the SLC2A1 can lead to glucose transporter type 1 deficiency syndrome (GLUT1DS), which is characterised by deficient glucose transport over the blood-brain barrier and reduced glucose availability in the brain. This can lead to a wide phenotypic variability e.g. microcephaly, delayed development, epilepsy, movement disorders, and cognitive impairment. | For removal of REAdye_lease fluorochromes for optional relabeling with different fluorochrome-conjugated REAdye_lease antibodies use the REAlease Support Kit (130-120-675). | |
| Immunogen | n/a |
| Other Names | GLUT-1, SLC2A1, Glucose transporter type 1, HepG2 glucose transporter |
| Gene, Accession # | n/a |
| Catalog # | 130-127-114 |
| Price | $470 |
| Order / More Info | GLUT1, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Schwantje, M. et al. (2020) Glucose Transporter Type 1 Deficiency Syndrome and the Ketogenic Diet. Am. J. Cancer Res. 43 (2): 216-222. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies